XUANZHU PHARMA
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.
XUANZHU PHARMA
Social Links:
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2002-01-01
Address:
Hebei, Hebei, China
Country:
China
Website Url:
http://www.xuanzhupharm.com
Total Employee:
251+
Status:
Active
Contact:
0531-80989300
Total Funding:
1.57 B CNY
Technology used in webpage:
SPF Apache Nginx DigiCert SSL IIS 8 GeoTrust SSL Encryption Everywhere Shockwave Flash Embed Alibaba Baidu Analytics
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Genevide
Genevide is a biotech company that specializes in gene research and development.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
YuiMedic
YuiMedic is a pharmaceutical company that conducts drug discovery research and develops pharmaceuticals.
Investors List
Hai Chuang Fund of Funds
Hai Chuang Fund of Funds investment in Series B - XuanZhu Pharma
Hainan Wanxin Private Equity Fund Management
Hainan Wanxin Private Equity Fund Management investment in Series B - XuanZhu Pharma
EFung Capital
EFung Capital investment in Series B - XuanZhu Pharma
BOC Capital
BOC Capital investment in Series B - XuanZhu Pharma
SDIC Taikang Trust
SDIC Taikang Trust investment in Series B - XuanZhu Pharma
Financial Holding Group
Financial Holding Group investment in Series B - XuanZhu Pharma
Huayi Capital
Huayi Capital investment in Series B - XuanZhu Pharma
TJ Capital
TJ Capital investment in Series B - XuanZhu Pharma
Jinjiang Xuanhong Equity Investment
Jinjiang Xuanhong Equity Investment investment in Series B - XuanZhu Pharma
Zhongji Investment
Zhongji Investment investment in Series B - XuanZhu Pharma
More informations about "XuanZhu Pharma"
XuanZhu Pharma - Crunchbase Company Profile
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, …See details»
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd.
Www.xuanzhupharm.com. Subsidiary Company | 2002 | Shandong Sheng, China | www.xuanzhupharm.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Xuanzhu Biopharm - Overview, News & Similar companies
Who is Xuanzhu Biopharm. Founded in 2002, Xuanzhu Biopharm is an innovative drug subsidiary of Sihuan Pharmaceutical. With a global perspective, focusing on tumors, metabol ic diseases, …See details»
Xuanzhu Biopharm Company Profile | Management and …
Xuanzhu Biopharm Profile and History. Founded in 2002, Xuanzhu Biopharm is an innovative drug subsidiary of Sihuan Pharmaceutical. With a global perspective, focusing on tumors, …See details»
XuanZhu Pharma Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XuanZhu Pharma Co., Ltd. of Jinan, Shandong. Get the latest business insights from Dun & Bradstreet.See details»
轩竹生物-助推中国新药发展服务人类健康
2012年四环全资收购100%股权后，轩竹成为国内大型医药集团四环医药的创新药子公司。2018年开始独立运营，2020年获先进制造产业投资基金、京津冀产业协同发展投资基金等国家级基 …See details»
XuanZhu Pharma - Craft
XuanZhu Pharma (轩竹医药) is a company engaged in drug research and development. It specializes in new molecular entity drugs (NMEs) focused on anti-infection and anti …See details»
Xuanzhu Biopharmaceutical Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Xuanzhu Biopharmaceutical Co., Ltd. of Shijiazhuang, Hebei. Get the latest business insights from Dun …See details»
轩竹生物科技股份有限公司-中国上市公司网 - ipo123.cn
轩竹生物科技股份有限公司是一家根植于中国、具有全球化视野的创新型制药企业，聚焦于消化、肿瘤及非酒精性脂肪性肝炎等重大疾病领域，致力于持续开发并商业化具有核心自主知识产权 …See details»
Xuanzhu Biopharmaceutical - Overview, News & Similar
View Xuanzhu Biopharmaceutical (www.xuanzhubio.com) location in 河北省, China , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Xuanzhu Biopharm - PitchBook
Xuanzhu Biopharm General Information Description. Developer of small molecule drugs and macromolecular biopharmaceuticals. The company develops innovative new drugs based on …See details»
XUANZHU Biopharmaceutical Ltd - VentureRadar
Open PageRank: 6,943,916 | xuanzhupharm.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times …See details»
山东轩竹医药科技有限公司 - 顺企网
公司邮箱：[email protected] 山东轩竹医药科技有限公司于2002年成立于山东济南，是中国领先的专业从事创新药物研究的企业，在日本建立分支机构以及长期合作单位，开辟了中国 …See details»
Shandong Xuanzhu Pharmaceutical Technology company profile
Oct 23, 2024 Shandong Xuanzhu Pharmaceutical Technology - Developer of therapies for treating cardiovascular diseases, cancer, and diabetes. Raised a total funding of $210M over 2 …See details»
Xuanzhu Biopharmaceutical Co., Ltd. - Drug pipelines, Patents
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into …See details»
Series B - XuanZhu Pharma - 2021-12-31 - Crunchbase
Jan 3, 2022 XuanZhu Pharma raised $96052486 on 2021-12-31 in Series B. Start Free Trial . Chrome ExtensionSee details»
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its …
HONG KONG, June 27, 2023 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd together with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., …See details»
JumpStart Magazine: Your Digital & Print Community Hub
Aug 24, 2020 Xuanzhu Biopharmaceutical welcomes Chinese government’s State Development and Investment Corporation as an investor. Xuanzhu Biopharmaceutical, a subsidiary of China …See details»
Xuanzhu Pharma discovers new PARP7 inhibitors for cancer
Dec 21, 2022 Xuanzhu Pharma Co. Ltd. has described protein mono-ADP-ribosyltransferase TIPARP (PARP7; ARTD14) inhibitors reported to be useful for the treatment of cancer.See details»
登录系统
请输入用户名和密码登录系统。See details»